Peter P Reese

Author PubWeight™ 47.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med 2014 7.25
2 Deceased organ donation consent rates among racial and ethnic minorities and older potential donors. Crit Care Med 2013 3.22
3 Improved renal ischemia tolerance in females influences kidney transplantation outcomes. J Clin Invest 2016 1.51
4 Barriers to living donor kidney transplantation among black or older transplant candidates. Clin J Am Soc Nephrol 2010 1.35
5 The costs and benefits of automatic estimated glomerular filtration rate reporting. Clin J Am Soc Nephrol 2009 1.31
6 More evidence that cystatin C predicts mortality better than creatinine. J Am Soc Nephrol 2009 1.28
7 Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol 2007 1.12
8 Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury. Pharmacoepidemiol Drug Saf 2012 1.11
9 Preimplant histologic acute tubular necrosis and allograft outcomes. Clin J Am Soc Nephrol 2014 1.04
10 Association between peritransplant kidney injury biomarkers and 1-year allograft outcomes. Clin J Am Soc Nephrol 2012 1.01
11 Is delayed graft function causally associated with long-term outcomes after kidney transplantation? Instrumental variable analysis. Transplantation 2013 1.00
12 Association Between Organ Procurement Organization Social Network Centrality and Kidney Discard and Transplant Outcomes. Transplantation 2015 0.95
13 Increased early graft failure in right-sided living donor nephrectomy. Transplantation 2011 0.95
14 Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes: a systematic review. Nephrol Dial Transplant 2012 0.94
15 Acute kidney injury, renal function, and the elderly obese surgical patient: a matched case-control study. Ann Surg 2013 0.94
16 Pregnancy outcomes among live kidney donors. Am J Transplant 2009 0.93
17 Medication misuse, nonadherence, and clinical outcomes among liver transplant recipients. Liver Transpl 2015 0.90
18 Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network. Pharmacoepidemiol Drug Saf 2012 0.89
19 Recipient risk factors associated with delayed graft function: a paired kidney analysis. Transplantation 2011 0.88
20 FGF23 modifies the relationship between vitamin D and cardiac remodeling. Circ Heart Fail 2013 0.87
21 Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies. Pharmacoepidemiol Drug Saf 2012 0.86
22 Inferior allograft outcomes in adolescent recipients of renal transplants from ideal deceased donors. Ann Surg 2012 0.85
23 Pretransplant physical activity predicts all-cause mortality in kidney transplant recipients. Am J Nephrol 2011 0.85
24 The kidney-first initiative: what is the current status of preemptive transplantation? Adv Chronic Kidney Dis 2012 0.84
25 Age, exclusion criteria, and generalizability of randomized trials enrolling kidney transplant recipients. Transplantation 2011 0.83
26 Biliary complications adversely affect patient and graft survival after liver retransplantation. Liver Transpl 2013 0.81
27 Eliminating racial disparities in access to living donor kidney transplantation: how can centers do better? Am J Kidney Dis 2012 0.81
28 A Paired Kidney Analysis of Multiorgan Transplantation: Implications for Allograft Survival. Transplantation 2017 0.79
29 Attitudes to sharing personal health information in living kidney donation. Clin J Am Soc Nephrol 2010 0.79
30 Reframing the impact of combined heart-liver allocation on liver transplant wait-list candidates. Liver Transpl 2014 0.79
31 Kidney transplantation in patients with a prior heart transplant. Transplantation 2010 0.78
32 Transplant-associated hyperglycemia: shedding light on the mechanisms. Clin J Am Soc Nephrol 2010 0.77
33 Actual and perceived knowledge of kidney transplantation and the pursuit of a live donor. Transplantation 2014 0.77
34 Financial incentives for living kidney donation: ethics and evidence. Clin J Am Soc Nephrol 2013 0.77
35 Health care follow-up by live kidney donors more than three yr post-nephrectomy. Clin Transplant 2012 0.77
36 Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals. Transplantation 2017 0.76
37 End-stage kidney disease after pediatric nonrenal solid organ transplantation. Pediatrics 2013 0.76
38 Donation after cardiac death liver transplantation is associated with increased risk of end-stage renal disease. Transpl Int 2014 0.76
39 Best option for transplant candidates with type 1 diabetes and a live kidney donor: a bird in the hand is worth two in the bush. Clin J Am Soc Nephrol 2009 0.76
40 Children first in kidney allocation: the right thing to do. Transpl Int 2014 0.75
41 Profiling live kidney donors in America: cause for optimism and for concern. Clin J Am Soc Nephrol 2010 0.75
42 Obesity, Renin-Angiotensin System Blockade and Risk of Adverse Renal Outcomes: A Population-Based Cohort Study. Am J Nephrol 2016 0.75
43 Utility of applying quality assessment tools for kidneys with KDPI ≥80. Transplantation 2016 0.75
44 The influence of induction therapy for kidney transplantation after a non-renal transplant. Clin J Am Soc Nephrol 2011 0.75
45 Delayed graft function phenotypes and 12-month kidney transplant outcomes. Transplantation 2016 0.75
46 Urine injury biomarkers are not associated with kidney transplant failure. Transplantation 2019 0.75
47 A Call for Research on Individuals Who Opt Out of Living Kidney Donation: Challenges and Opportunities. Transplantation 2016 0.75
48 Should living kidney donors with hypertension be considered for organ donation? Curr Opin Nephrol Hypertens 2015 0.75
49 The case against imminent death donation. Curr Opin Organ Transplant 2016 0.75
50 Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation: Report of the Standardized Outcomes in Nephrology-Kidney Transplantation Consensus Workshops. Transplantation 2017 0.75
51 Shining a light on the murky problem of discarded kidneys. Transplantation 2016 0.75
52 Nutrition assessment and counseling of the medically complex live kidney donor. Nutr Clin Pract 2014 0.75
53 Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes. Transplantation 2012 0.75